Richard Hirschman funeral, Director and embalmer has mRNA vaccines Clots

“DSPC is a phospholipid commonly used in lipid nanoparticles (LNPs) for drug delivery, including mRNA vaccines1. When DSPC enters the bloodstream, it can interact with various enzymes and proteins. One key interaction is with enzymes involved in the clotting cascade, such as thrombin and fibrinogen.
Here’s a more detailed breakdown of the process:
1Initial Interaction: DSPC molecules, due to their amphiphilic nature, integrate into the lipid bilayers of cell membranes or form micelles in the bloodstream. This integration can disrupt normal cellular processes.
2Enzyme Activation: The presence of DSPC can activate enzymes like thrombin, which plays a crucial role in converting fibrinogen to fibrin. Fibrin is the protein that forms the mesh-like structure of blood clots.
3Abnormal Fibrin Formation: The interaction between DSPC and thrombin might lead to the production of abnormal fibrin structures. These structures could be more prone to aggregation, forming the white clots observed.
4Aggregation and Clot Formation: The abnormal fibrin structures aggregate more readily, leading to the formation of larger, more stable clots. These clots can obstruct blood flow, causing various health issues.
5Immune Response: The body might recognize these abnormal clots as foreign, triggering an immune response. This response can exacerbate the clotting process, leading to further complications.”
https://x.com/r_hirschman/status/1817578271091122466?s=46